Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT02488967||Recruiting||Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer||
||Other / NIH||
||990||All||18 Years and older (Adult, Older Adult)||NCT02488967||NRG-BR003
|July 2015||April 2021||July 2, 2015||October 5, 2016||